Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nely Mercy Diaz Mejia"'
Autor:
Esmail Al-Ezzi, Abhenil Mittal, Zachary W. Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Osama Abdeljalil, Husam Alqaisi, Vikaash Kumar, Aaron R. Hansen, Nazanin Fallah-Rad, Srikala S. Sridhar
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 1 (2024)
Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients with metastatic clear cell renal cell carcinoma (RCC). The evidence supporting their use in metastatic nonclear cell renal cell carcinoma (nccRCC) subtype
Externí odkaz:
https://doaj.org/article/b7d3d94769e84d84a091c0eecef9f662
Autor:
Esmail Mutahar Al-Ezzi, Abhenil Mittal, Zachary William Neil Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Osama Abdeljalil, Husam Alqaisi, Vikaash Kumar, Nazanin Fallah-Rad, Srikala S. Sridhar
Publikováno v:
Journal of Clinical Oncology. 41:636-636
636 Background: Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients (pts) with advanced clear cell renal cell carcinoma. The evidence to support their use in metastatic non-clear cell renal cell carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714510496686bfa3da09473c65349aaf
https://doi.org/10.1200/jco.2023.41.6_suppl.636
https://doi.org/10.1200/jco.2023.41.6_suppl.636
Autor:
Nely Mercy Diaz Mejia, Carlos Stecca, Di Maria Jiang, Nazanin Fallah-Rad, Philippe L. Bedard, Vikaash Kumar, Osama Abdeljalil, Amer Zahralliyali, Husam Alqaisi, Esmail Mutahar Al-Ezzi, Vivian Choy, Parmvir Banwait, Eshetu Atenafu, Srikala S. Sridhar
Publikováno v:
Journal of Clinical Oncology. 41:115-115
115 Background: To mitigate the risks of chemotherapy associated neutropenia, during the COVID-19 pandemic, all genitourinary (GU) cancer patients treated with chemotherapy at the Princess Margaret Cancer Centre (PMCC) were offered primary prophylaxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e9cd07537565af0afa89c3c776d8cb
https://doi.org/10.1200/jco.2023.41.6_suppl.115
https://doi.org/10.1200/jco.2023.41.6_suppl.115